Canada added 2,844 new cases of the novel coronavirus on Monday, pushing the total number of infections in the country to 913,052.
Health officials in the provinces also confirmed 25 more people have died after testing positive for COVID-19.
Since the virus was first detected, it has claimed 22,495 lives in Canada.
Story continues below advertisement
0:48 Canada to receive 1M Pfizer vaccine doses per week until early May
Canada to receive 1M Pfizer vaccine doses per week until early May
In a series of tweets Monday, Canada’s top doctor Theresa Tam, said Canada is “at a crossroads of controlling non-variant COVID-19 spread” and the “increasing new variant cases,” particularly in Ontario, Alberta, British Columbia and Quebec.
“Our progress has stalled,” she wrote, adding that case counts have increased.
Tam said as vaccination efforts expand in the weeks and months to come, “things will get easier,” but she urged Canadians to continue to abide by public health measures to stem the spread of the virus.
So far, Canada has administered more than 3.1 million COVID-19 vaccines, meaning approximately 4.16 per cent of the country’s population has been inoculated.
Speaking at a press conference in Montreal on Monday, Prime Minister Justin Trudeau urged Canadians to take the first vaccine that is offered to them.
His comments come as several European countries suspended the use of the AstraZeneca-Oxford COVID-19 vaccine over reports of blood clots.
Trudeau said Health Canada regulators are constantly analyzing all the available information about vaccines and have guaranteed those approved in Canada are safe for use.
“Health Canada and our experts and scientists have spent an awful lot of time making sure every vaccine approved in Canada is both safe and effective,” he told reporters.
“Therefore, the very best vaccine for you to take is the first one that is offered to you.”
Story continues below advertisement
0:28 Coronavirus will remain in global population ‘for some time,’ Tam says
Coronavirus will remain in global population ‘for some time,’ Tam says
In a statement emailed to Global News on Sunday, Health Canada said at this time, “there is no indication that the vaccine caused these events.”
“To date, no adverse events related to the AstraZeneca COVID-19 vaccine, or the version manufactured by the Serum Institute of India, have been reported to Health Canada or the Public Health Agency of Canada,” the email read.
New cases, deaths in the provinces
In Ontario, 1,268 new cases of the coronavirus and nine more deaths were detected.
No new cases were reported in any of Canada’s territories on Monday and health officials confirmed no one else has died.
Global cases top 120 million
Globally, more than 120 million people have been infected with the novel coronavirus, according to the latest tally from Johns Hopkins University.
By Monday afternoon the total number of COVID-19 cases worldwide was 120,176,364.
Since the virus was first detected in Wuhan, China in late 2019, more than 2.6 million people have died after testing positive for the disease.
The United States remained the viral epicentre on Monday, with over 29.4 million infections and more than 535,400 fatalities associated with the respiratory illness.
TORONTO – Cineplex Inc. reported a loss in its latest quarter compared with a profit a year ago as it was hit by a fine for deceptive marketing practices imposed by the Competition Tribunal.
The movie theatre company says it lost $24.7 million or 39 cents per diluted share for the quarter ended Sept. 30 compared with a profit of $29.7 million or 40 cents per diluted share a year earlier.
The results in the most recent quarter included a $39.2-million provision related to the Competition Tribunal decision, which Cineplex is appealing.
The Competition Bureau accused the company of misleading theatregoers by not immediately presenting them with the full price of a movie ticket when they purchased seats online, a view the company has rejected.
Revenue for the quarter totalled $395.6 million, down from $414.5 million in the same quarter last year, while theatre attendance totalled 13.3 million for the quarter compared with nearly 15.7 million a year earlier.
Box office revenue per patron in the quarter climbed to $13.19 compared with $12 in the same quarter last year, while concession revenue per patron amounted to $9.85, up from $8.44 a year ago.
This report by The Canadian Press was first published Nov. 6, 2024.
TORONTO – Restaurant Brands International Inc. reported net income of US$357 million for its third quarter, down from US$364 million in the same quarter last year.
The company, which keeps its books in U.S. dollars, says its profit amounted to 79 cents US per diluted share for the quarter ended Sept. 30 compared with 79 cents US per diluted share a year earlier.
Revenue for the parent company of Tim Hortons, Burger King, Popeyes and Firehouse Subs, totalled US$2.29 billion, up from US$1.84 billion in the same quarter last year.
Consolidated comparable sales were up 0.3 per cent.
On an adjusted basis, Restaurant Brands says it earned 93 cents US per diluted share in its latest quarter, up from an adjusted profit of 90 cents US per diluted share a year earlier.
The average analyst estimate had been for a profit of 95 cents US per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.
ST. JOHN’S, N.L. – Fortis Inc. reported a third-quarter profit of $420 million, up from $394 million in the same quarter last year.
The electric and gas utility says the profit amounted to 85 cents per share for the quarter ended Sept. 30, up from 81 cents per share a year earlier.
Fortis says the increase was driven by rate base growth across its utilities, and strong earnings in Arizona largely reflecting new customer rates at Tucson Electric Power.
Revenue in the quarter totalled $2.77 billion, up from $2.72 billion in the same quarter last year.
On an adjusted basis, Fortis says it earned 85 cents per share in its latest quarter, up from an adjusted profit of 84 cents per share in the third quarter of 2023.
The average analyst estimate had been for a profit of 82 cents per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.
